KIAA1429 enhances FOXM1 mRNA stability by targeting its m6A modification sites, thereby increasing gastric cancer cells’ resistance to oxaliplatin and cisplatin (Tang et al., 2023; Zhu Z. et al., 2022). This evidence concerns the gene VIRMA and gastric cancer.